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1. Introduction 
The analysis of exhaled breath has been used in medicine 
since ancient times for the diagnosis of various disorders. 
In 1970s Linus Pauling has shown that exhaled breath 
contains thousands of volatile molecules which levels are 
strongly related to airway and systemic metabolism and 
oxidative stress. In 1980s Sidorenko et al. condensed the 
expired air and successfully isolated proteins from 
exhaled breath condensate (EBC) fluid, thus inventing a 
method to analyse the non-volatile compounds of the 
airways. In the last decades, numerous studies proved 
that the composition of exhaled breath is altered in 
various pulmonary and extrapulmonary diseases. 
However, the number of breath test used in daily routine 
is low. The main reason for this is that the 
methodological and physiological factors affecting the 
exhaled breath results were not investigated thoroughly.  
The most studied biomarker in EBC is pH. It is suggested 
that the acidity of EBC is not only determined by the pH 
of airway droplets but by volatile acids and bases 
dissolving into the condensate. Moreover, the 
interpretation of EBC results is complicated by a variable 
(1:50-1:50000) amount of alveolar water diluting the 
airway droplets. Our workgroup has previously validated 
a method to detect the magnitude of dilution by the 
measurement of conductivity of vacuum treated EBC 
samples; however the effect of dilution on EBC pH has 
not been investigated before. 
The electronic nose is a potential technique to study 
exhaled volatile compounds. Similarly to mammalian 
olfaction, it is not able to analyse the qualitative or 
quantitative modalities of the gas mixture, but can 
distinguish different gas composites based on their 
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molecule pattern. Cyranose 320 is the most widely used 
electronic nose in respiratory research, and it could 
differentiate exhaled breath of patients with asthma, 
COPD or lung cancer from those of healthy individuals. 
Nonetheless, only few studies have investigated the short 
and long term reproducibility of Cyranose 320.   
Similarly to diseases, physiological processes, such as 
physical exercise or physiological pregnancy could also 
modify the levels of exhaled biomarkers. 
Physical exercise increases cardiac output and minute 
ventilation, changes airway and systemic metabolism as 
well as oxidative stress and it induces airway 
inflammatory response.   
Physiological pregnancy is characterised by accelerated 
metabolism, elevated systemic oxidative stress, altered 
hormone levels, immune tolerance and increased 
production of pheromones. 
The hereby presented research was dedicated to 
investigate the importance of previously not studied 
methodological and physiological factors on exhaled 
biomarkers, thus facilitating the clinical application of 
exhaled breath analysis. 
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2. Objectives 
1. To study the relationship between EBC pH and 
respiratory droplet dilution. 
2. To study the short and long term reproducibility 
of Cyranose 320. 
3. To study the effect of physical exercise on 
exhaled volatile compounds and EBC pH. 
4. To study the effect of pregnancy on exhaled 
volatile compounds.  
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3. Methods 
3.1. Study subjects 
In total, 308 volunteers participated in the four studies. 
The asthmatic subjects were recruited at the asthma 
outpatient clinic of the Department of Pulmonology, 
Semmelweis University. Asthma was diagnosed 
according to the Global Initiative for Asthma (GINA) 
guideline and confirmed by >12% and 200 mL increase 
in FEV1 after administration of 400 µg salbutamol. None 
of the subjects was hospitalised due to asthma 
exacerbation in the last year, indicating that the patients 
were considered stable. 
The pregnant individuals were recruited at the 1
st
 
Department of Obstetrics and Gynecology, Semmelweis 
University. In total, 78 pregnant women were 
investigated, 63 in the 3
rd
 trimester and 15 in the 2
nd
 
trimester. 
The healthy controls were recruited among students and 
workers of Semmelweis University. 
All subjects enrolled signed an informed consent prior to 
the experiments. 
3.2. Study designs 
The relationship between EBC pH and dilution was 
investigated in 55 healthy and 57 asthmatic subjects. 
Exhaled breath condensate was collected in all 
individuals for pH and dilution measurements. The two 
parameters were correlated within the asthmatic and the 
healthy groups as well as all together. 
Investigating the short term reproducibility of Cyranose 
320, exhaled breath samples were analysed at baseline 
and also 10 minutes after in 56 healthy subjects. The long 
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term reproducibility was analysed in 12 healthy 
volunteers who donated exhaled breath samples for 8 
weeks. 
The effect of physical exercise on exhaled biomarkers 
was studied in 10 healthy individuals. Before as well as 
0, 15, 30 and 60 minutes after an outdoor exercise 
challenge test exhaled breath samples were collected for 
volatile compound and pH measurements. 
The effect of pregnancy was analysed in 118 women. In 
the first phase of the study, exhaled breath samples were 
compared between 48 3
rd
 trimester pregnant women and 
25 non-pregnant women. Based on the statistical model 
set in the first phase, breath samples of 30 pregnant (15 
2
nd
 trimester and 15 3
rd
 trimester) and 15 non-pregnant 
women were categorised into the preset groups.  
3.3. Exhaled breath tests 
Exhaled breath condensate was collected for 10 minutes 
using the Rtube device (Respiratory Research, 
Charlottesville, VI, USA). The subjects were breathing 
with tidal volumes and were not wearing nose clip. The 
chilling tube was previously cooled at -80 °C. The 
samples were stored at -80 °C until analysis. 
To collect volatile compounds Teflon coated and poly-
vinyl-chloride bags were used. After inhalation of VOC-
filtered air, subjects exhaled to residual volume at 
controlled expiratory flow (50 mL/sec) against resistance 
(15-20 cmH2O). The first 500 mL of exhaled air, 
representing the anatomical dead space was discarded 
and the remaining alveolar space air was analysed. The 
collection protocol during physical exercise was 
different. Subjects were asked to inhale through their 
nose and exhale into a three-litre poly-vinyl-chloride bag 
three times. During the exhalation the dead space was not 
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discarded and the expiratory flow was not controlled. 
After the third exhalation the bag was closed with a clip 
and analysed immediately. 
The EBC pH was determined using the argon purging 
and the carbon dioxide loading methods. 
The dilution factor was estimated following 24-hour 
vacuum evaporation of condensate as well as serially 
diluted saline samples. After reconstitution with distilled 
water conductivity was measured in each condensate and 
saline sample. 
The Cyranose 320 electronic nose (Smiths Detection, 
Pasadena, USA) was used for exhaled volatile compound 
analysis. The confounding effect of water vapour was 
eliminated after exclusion of 4 water-sensitive sensors 
(5,6,23,31). The 28 sensor data were generated by the 
ratio of samples responses and the background (VOC-
filtered room air in our measurements). The data 
underwent data reduction using the prinical component 
analysis (PCA). The highest 3 principal components 
(PCs) were used for further analysis. 
3.4. Statistical analysis 
We used commercially available statistical programs 
(Statistica 8.0, SPSS 15, Graph Pad Prism 5.03) for 
statistical analyses.  
Mann-Whitney test was used to compare EBC pH and 
dilution values between asthmatics and healthy subjects. 
The relationship between EBC pH and dilution was 
analysed with Spearman correlation. 
Investigating the short term reproducibility of Cyranose 
320, the principal components representing the baseline 
and 10-minute measurements were compared with paired 
t-test and Pearson test. Analysing the long term 
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reproducibility principal components were compared 
using ANOVA and Pearson correlation.   
The effect of physical exercise on exhaled biomarkers 
was studied using mixed-linear model. EBC pH was 
correlated to principal components using the Pearson test. 
Mahalanobis distance, a discrimination technique was 
used to compare pregnant and non-pregnant breath 
samples. We also used Mahalanobis distance to 
categorise the new 45 samples into the previously preset 
groups. Pearson test was used to investigate the 
relationship between the principal components and 
gestational age. 
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4. Results 
4.1. Relationship between EBC pH and 
dilution 
We did not find any significant difference in EBC pH 
(7.91 (7.31-8.04) and 7.83 (7.54-8.05)) or dilution (2326 
(1460-4630) vs. 2646 (1435-3969)) between the 
asthmatic and healthy groups (p>0.05). 
There was a negative correlation between EBC pH and 
dilution in the asthmatic (r=-0.35, Figure 1A) as well as 
healthy groups (r=-0.29, Figure 1B) 
 
Figure 1. 
The relationship between EBC pH and dilution 
in the asthmatic (A) and healthy (B) subjects 
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4.2. Reproducibility of Cyranose 320  
We did not find any significant difference between the 
two breath samples collected at baseline and after 10 
minutes assessing the principal components (p=0.85, 0.41 
and 0.63, PC1, PC2 and PC3, respectively). Nonetheless, 
there was a significant relationship between the two 
samples (r=0.51, 0.75, and r=0.37, PC1, PC2 and PC3, 
respectively, all p<0.05). 
There was no difference in electronic nose results during 
the 8 weeks of follow up (p>0.05). 
 
4.3. Effect of physical exercise on exhaled 
biomarkers 
Physical exercise significantly increased EBC pH and 
altered exhaled volatile compound pattern (Figure 2). 
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Figure 2 
Effect of exercise on exhaled volatile compound 
pattern and EBC pH 
 
There was a significant relationship between EBC pH 
and exhaled volatile compound pattern (p=0.01, r=-0.34). 
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4.4. Effect of pregnancy on exhaled volatile 
compounds 
We found a significant difference comparing exhaled 
breath samples obtained from 48 pregnant and 25 non-
pregnant volunteers (p=0.015). After excluding subjects 
with accompanying disorders (hay fever, diabetes, 
hypothyreosis) and smokers, the level of discrimination 
was higher (p=0.001). 
There was a significant relationship between exhaled 
volatile compound pattern and the gestational weeks 
(p=0.01, r=-0.36). 
Comparing 15 pregnant women in the 3
rd
 trimester and 
15 non-pregnant subjects to the preset model based on 20 
pregnant and 18 non-pregnant healthy non-smoker 
subjects the electronic nose could discriminate the new 
volunteers with 87% sensitivity, 73% specificity, 76% 
positive predictive value and 84% negative predictive 
value (Figure 3). However, the 15 2
nd
 trimester women 
were classified poorly. 
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Figure 3 
Circles represent pregnant, squares represent 
non-pregnant samples. The open signs 
represent the original (20 pregnant and 18 
non-pregnant) the full signs represent the new 
(15 pregnant and 15 non-pregnant) groups.     
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5. Conclusions 
5.1. Relationship between EBC pH and 
dilution 
 There is no significant difference in EBC pH or 
EBC dilution between subjects with stable asthma 
and healthy controls.  
 EBC pH is influenced by respiratory droplet 
dilution.  
5.2. Reproducibility of Cyranose 320 
 The electronic nose results are reproducible 
within short (within a day) and long term (8 
weeks). 
5.3. Effect of physical exercise on exhaled 
biomarkers 
 Physical exercise increases EBC pH and alters 
exhaled volatile compound pattern. 
 EBC pH is influenced by exhaled volatile 
compounds. 
5.4. Effect of pregnancy on exhaled volatile 
compounds 
 Pregnancy alters the exhaled volatile compound 
pattern.  
 The production of exhaled volatile compounds 
changes during pregnancy.  
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